Businesses investing in research and experimental (R&E) activities are set to benefit from a significant tax update in 2025. On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) reinstated the immediate deduction for U.S.-based R&E expenses. This reversal undoes a major provision of the Tax Cuts and Jobs Act (TCJA), which previously required companies to capitalize and amortize R&E expenses over five years (or 15 years for international research).
This shift has the potential to create substantial savings and improve cash flow for businesses engaged in innovation, technology, and development.
Maximizing Your R&E Tax Opportunities
The immediate deduction for qualifying domestic R&E expenses begins with eligible 2025 costs, but there are several strategies that businesses should consider to maximize their benefits:
1. File Retroactive Claims
Small businesses — defined as those with average annual gross receipts of $31 million or less over the past three years — may apply the new rule retroactively. By filing amended returns for 2022, 2023, and/or 2024, you could claim the immediate deduction and secure tax refunds for those years. Remember, these amended returns must be filed by July 4, 2026.
2. Accelerate Remaining Deductions
Companies that began capitalizing and amortizing R&E expenses in prior years (2022–2024) may deduct the remaining balance in full on their 2025 return or split it between their 2025 and 2026 returns. This provides faster access to deductions that would otherwise be spread over several years.
3. Reevaluate Research Locations
With the new rules, domestic research offers even greater advantages. Previously, the five-year vs. 15-year amortization periods made U.S.-based research more attractive than foreign activities. Now, the ability to immediately deduct domestic R&E costs makes relocating research operations to the U.S. a tax-savvy decision.
4. Don’t Overlook the Research Credit
While deductions reduce taxable income, R&E tax credits directly reduce the tax you owe, dollar-for-dollar. If your company qualifies for the credit for “increasing research activities,” this could deliver even greater savings. However, keep in mind that the definition of qualifying expenses for the credit is narrower than for deductions — and you cannot claim both on the same costs.
Why This Matters for Your Business
These changes provide a powerful opportunity to improve cash flow, strengthen your financial position, and reinvest in innovation. Whether you’re a startup exploring cutting-edge technology or an established company with ongoing R&D initiatives, planning ahead will help you maximize every tax advantage available.
Partner with Botwinick for Expert Guidance
Navigating these new R&E tax rules can be complex, but you don’t have to do it alone. At Botwinick & Co., CPAs, our team specializes in helping businesses take full advantage of evolving tax laws. We’ll analyze your situation, identify strategies tailored to your business, and guide you through every step — from amended filings to planning future research investments.
Contact us today to discuss how these changes impact your company and learn how to maximize your tax savings in 2025 and beyond.
